Back
Nuvalent Vs. Replimune Group Industry Stock Comparison
Sell
36
NUVL
Nuvalent
Last Price:
94.89
Seasonality Move:
7.57%
Buy
56
REPL
Replimune Group
Last Price:
14.93
Seasonality Move:
-7.17%
Sell
36
Nuvalent (NUVL)
is a Sell
Is Nuvalent a Buy, Sell or Hold?
- The current Nuvalent [NUVL] share price is $94.93. The Score for NUVL is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- NUVL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Replimune Group (REPL)
is a Buy
Is Replimune Group a Buy, Sell or Hold?
- The current Replimune Group [REPL] share price is $14.93. The Score for REPL is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- REPL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
REPL Stock Price Chart
What is Replimune Group's stock price today?
-
The Replimune Group share price today is $14.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REPL is experiencing slight selling pressure.
NUVL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.16 | Sell |
| Relative Strength Index (14 RSI): | 54.2 | Buy |
| Chaikin Money Flow: | 321515 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (88.78 - 95.92) | Buy |
| Bollinger Bands (100): | (77.27 - 99.55) | Buy |
REPL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 72.51 | Buy |
| Chaikin Money Flow: | -418073 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.12 - 12.72) | Buy |
| Bollinger Bands (100): | (9.74 - 11.84) | Buy |
NUVL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 90.6 | Buy |
| 20-day SMA: | 91.35 | Buy |
| 50-day SMA: | 97.8 | Sell |
| 200-day SMA: | 81.76 | Buy |
| 8-day EMA: | 91.86 | Buy |
| 20-day EMA: | 92.51 | Buy |
| 50-day EMA: | 92.95 | Buy |
| 200-day EMA: | 81.99 | Buy |
REPL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.6 | Buy |
| 20-day SMA: | 11.95 | Buy |
| 50-day SMA: | 11.58 | Buy |
| 200-day SMA: | 9.13 | Buy |
| 8-day EMA: | 12.09 | Buy |
| 20-day EMA: | 11.87 | Buy |
| 50-day EMA: | 11.48 | Buy |
| 200-day EMA: | 10.61 | Buy |
Nuvalent Earnings Growth & NUVL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.61 per share, and a decrease next year of $0.69 per share.
Replimune Group Earnings Growth & REPL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.35 per share, and an increase next year of $0.52 per share.
Nuvalent Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Replimune Group Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||